BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading contract development and manufacturing organization (CDMO), announced today its proprietary formulation design and development ...

With a cash runway that extends into 2026, Design has the money to deliver phase 1 data on its updated formulation—a milestone penciled in for the first half of 2025—but the program is now ...

CD Formulation's performance testing approach sets a new benchmark in ensuring the integrity and optimization of microneedle structure design. By analyzing drug loading, homogeneity, strength, and ...